1. Tackling antibiotic resistance during the COVID‐19 pandemic is a new challenge for paediatricians
- Author
-
Yock-Corrales A., Lenzi J., Brizuela M., Valentini P., Buonsenso D., Antunez-Montes O. Y., Escamilla M. I., Figueroa-Uribe A. F., Arteaga-Menchaca E., Lavariega-Sarachaga M., Salcedo-Lozada P., RA S., Melchior P., Tirado-Caballero J. C., Tasayco-Munoz J. A., Pinzon-Redondo H., Montes-Fontalvo L. V., Ochoa T., Campos F. E., Hernandez R., Limansky L., Del Aguila O., Ulloa-Gutierrez R., Gomez-Vargas J., Rios Aida J. A., Buitrago A. P., Betancur Londono L. M., Uribe F., Yock-Corrales A., Lenzi J., Brizuela M., Valentini P., Buonsenso D., Antunez-Montes O.Y., Escamilla M.I., Figueroa-Uribe A.F., Arteaga-Menchaca E., Lavariega-Sarachaga M., Salcedo-Lozada P., RA S., Melchior P., Tirado-Caballero J.C., Tasayco-Munoz J.A., Pinzon-Redondo H., Montes-Fontalvo L.V., Ochoa T., Campos F.E., Hernandez R., Limansky L., Del Aguila O., Ulloa-Gutierrez R., Gomez-Vargas J., Rios Aida J.A., Buitrago A.P., Betancur Londono L.M., and Uribe F.
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,COVID-19 ,Drug Resistance, Microbial ,General Medicine ,Drug resistance ,Prescription ,Systemic Inflammatory Response Syndrome ,Latin America ,Antibiotic resistance ,Pediatrician ,Anti-Bacterial Agent ,Pediatrics, Perinatology and Child Health ,Pandemic ,Medicine ,Child ,business ,Intensive care medicine ,Pandemics ,Human - Published
- 2021
- Full Text
- View/download PDF